Amiodarone Hydrochloride NDC 70518-3246

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3246Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3246Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3246-1	70518324601	50 POUCH in 1 BOX (70518-3246-1) / 1 TABLET in 1 POUCH (70518-3246-2)Marketed from Apr 22, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amiodarone Hydrochloride
Generic name (nonproprietary): amiodarone hydrochloride
Active ingredients: Amiodarone hydrochloride — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213446
Marketing start: Oct 15, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 70518-3246_584f8c98-a7ba-67ac-e063-6294a90a56d6SPL ID 584f8c98-a7ba-67ac-e063-6294a90a56d6SPL set ID 4c149392-a4f0-4e2d-a13f-2b94810005deRxCUI 833528UNII 976728SY6Z
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518324601 followed by a unit qualifier and the quantity

Package 70518-3246-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. Amiodarone hydrochloride tablets are an antiarrhythmic indicated for: Recurrent ventricular fibrillation. ( 1 ) Recurrent hemodynamically unstable ventricular tachycardia. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213446

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213446
Product	Strength	Form · route	Labeler	Product NDC
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	A-S Medication Solutions	50090-5766
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-359
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Bryant Ranch Prepack	71335-1942
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Redpharm Drug	67296-2296